TARA250117C5000
- 0.50
- -0.15-23.08%
Protara Therapeutics Newsroom
Protara Therapeutics Closes $100 Million Securities Offering
Protara Therapeutics 13.69M Share Spot Secondary Priced at $6.25
Protara: Gross Proceeds From Offering Expected to Be Approximately $100M >TARA
Protara Announces Pricing of 13.69M Shares of Common Stock at $6.25 Per Share>TARA
Protara: Offering Is Expected to Close Dec. 11 >TARA
Protara Therapeutics Launches Common Stock Offering; Shares Fall After Hours
Express News | Protara Therapeutics Inc - to Use Proceeds to Fund Clinical Development of Tara-002
Press Release: Protara Announces Proposed Public Offering
Institutions Profited After Protara Therapeutics, Inc.'s (NASDAQ:TARA) Market Cap Rose US$60m Last Week but Individual Investors Profited the Most
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating
We Think Protara Therapeutics (NASDAQ:TARA) Needs To Drive Business Growth Carefully
H.C. Wainwright Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $23
Promising Efficacy of TARA-002 Positions Protara Therapeutics as a Compelling Buy for HR-NMIBC Treatment
Express News | HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
Protara Therapeutics Analyst Ratings
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Crude Oil Edges Lower; US Initial Jobless Claims Increase